This study is conducted in the United States of America (USA). The aim of this study is to assess longitudinal variation of immune biomarkers in subjects with type 1 diabetes (T1D), type 2 diabetes (T2D) and healthy, non-diabetic subjects over a one year period.
Study Type
OBSERVATIONAL
Enrollment
61
The participants will not receive any treatment
Novo Nordisk Investigational Site
Princeton, New Jersey, United States
Variation in CD8 (cluster of differentiation) +T-cell specificity profiling
Time frame: Over a one year period
Variation in CD4 +T-cell specificity profiling
Time frame: Over a one year period
Change in stimulated C-peptide
Time frame: Baseline, one year
Fluctuation in islet autoantibodies titers
Time frame: Over a one year period
Variation in HbA1c (glycosylated haemoglobin)
Time frame: Over a one year period
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.